The past decade has witnessed dramatic changes in the etiology, diagnosis, and management of community acquired pneumonia (CAP). Due to the wide variation in practice patterns, physicians and professional societies have taken the lead in developing practice guidelines. To better understand the range of these multiple protocols, various stages of the disease and treatment are described and compared. Experts agree that CAP management should include: defining a correct diagnosis, identifying high risk populations in order to determine the severity of the disease, recommending appropriate treatment therapies, and obtaining positive and cost beneficial outcomes.
This is a preview of subscription content,to check access.
Access this article
Similar content being viewed by others
Fine, M.J., Auble, T.E., Yealy, D.M., et al., A prediction rule to identify low risk patients with community acquired pneumonia. N. Engl. J. Med. 336(4):243–50, 1997.
Bartlett, J.G., Brieman, R.F., Mandell, L.A., et al., Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:811–38, 1998.
Rubins, J.B., and Janoff, E.N., Community-acquired pneumonia. Tailoring management of adult patients according to risk category. Postgrad. Med. 102:45–62, 1997.
Talan, D.A., New concepts in antimicrobial therapy for emergency department infections. Ann. Emerg. Med. 34(4):503–16, 1999.
Meehan, T.P., Fine, M.J., Krumholtz, H.M., et al., Quality of care, process and outcome in elderly patients with pneumonia. JAMA. 278:2080–4, 1997.
Henning, J.M., The role of clinical practice guidelines in disease management. Am. J. Manag. Care 4:1715–24, 1998.
Gilbert, K., Gleason P.P., Singer, D.E., et al., Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia. Am. J. Med. 104:17–27, 1998.
Fine, M.J., Smith. A.M., Carson, C.A., et al., Prognosis and outcomes of patients with community acquired pneumonia. A meta analysis. JAMA 275(2):134–41, 1996.
Lynch, J.P., and Martinez, J.P., Community-acquired pneumonia. Curr. Opin. Pul. Med. 4:162–72, 1998.
Benson-Sardo, P., Community-Acquired Pneumonia: Achieving optimal outcomes in antimicrobial therapy. Am. J. Manag. Care 5(9): S529-35, 1999.
Bartlett, J.G., Hillman, A.L., Niederman, M.S., et al., Clinical and economic consequences on early intervention in community-acquired pneumonia. Infect. Dis. Clin. Pract. 5(suppl. 4):S179–84, 1996.
Interview with Maury Rottenberg, MD. Northwest Community Hospital, Internal Medicine Department. Arlington Heights, IL.
Interview with Jesse Park M.D., Rush Prudential Health Care, Internal Medicine Department. Oak Brook, IL.
Siegel, R., Community acquired pneumonia: incidence, epidemiology, and current therapeutic management. Am. J. Manag. Care 5(9):S525–8, 1999.
Nierderman, M.S., Bass, J.B., Jr., Campbell, G.D., et al., American thoracic society. Guidelines for the initial management of adults with community acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148:1418–26, 1993.
Balentine, J., Battleman, D., and Callahan, M., Initiating antibiotic therapy in the emergency department decreases length of stay for patients with the diagnosis of community-acquired pneumonia. Ann. Emerg. Med. 34(4, part 2):S28, 1999.
Interview with William Werner, MD., Illinois Masonic Hospital, Quality Improvement Department. Chicago, IL.
Lega, M., Emergency room evaluation and management of the immunosuppressed patient with pneumonia. Top. Emerg. Med. 21(4):11–28, 1999.
Shuster, L.T., McDougall, J.C., Pneumonia management guidelines—why, how, and where to start. Mayo Clinic Proc. 73(1):96–7, 1998.
Huber, S.L., Wood, J.G., Weston, J.S., et al., Antibiotic Therapy in community acquired pneumonia and the role of the hospital pharmacist. Am. J. Manag. Care 5(9):S555–69, 1999.
Stahl, J.E., Barza, M., DesJardin, J., et al., Effect of macrolides as part of initial empiric therapy on length of stay in-patients hospitalized with community acquired pneumonia. Arch. Intern. Med. 159(21):2576–80, 1999.
Gleason, P.P., Kapoor, W.N., Stone, R.A., et al., Medical outcomes and antimicrobial costs with the use of the American thoracic Society guidelines for outpatients with community acquired pnuemonia. JAMA 278:32–9, 1997.
Gugliemo, B.J., Dudas, V., Tran, S., et al., Treatment outcomes associated with community acquired pneumonia in U.S. hospitals: a 3,000 patient survey. Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Sept., 1997; Toronto, Ontario.
Kraemer, K.L., Saitz, R., Obrosky, D. S., et al., The effect of alcohol abuse on community acquired pneumonia outcomes and processes of care. J. Gen. Intern. Med. 12(S1):53, 1997.
Markowitz, J.S., Pashko, S., Gutterman, E.M., et al., Death rates among patients hospitalized with community-acquired pneumonia: a reexamination with data from three states. Am. J. Public Health 86:1152–4, 1996.
Marston, B.J., Plouffe, J.F., File, T.M., Jr., et al., Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch. Intern. Med. 157:1709–18, 1997.
Ramirez J.A., Vargas, S., Ritter, G.W., et al., Early switch from intravenous to oral antibioitics and early hospital discharge: a prospective observational study of 200 consecutive patients with community acquired pneumonia. Arch. Intern. Med. 159(20):2449–5, 1999.
About this article
Cite this article
Hasnain, M., Clark, E.J. Management Strategies for Community Acquired Pneumonia. Journal of Medical Systems 24, 279–288 (2000). https://doi.org/10.1023/A:1005540208406